An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Uğur Şahin, Petra Oehm, Evelyna Derhovanessian, Robert A. Jabulowsky, Mathias Vormehr, Maike Gold, Daniel Maurus, Doreen Schwarck-Kokarakis, Andreas N. Kuhn, Tana Omokoko, Lena M. Kranz, Mustafa Diken, Sebastian Kreiter, Heinrich Haas, Sebastian Attig, Richard Rae, Katarina Ćuk, Alexandra Kemmer-Brück, Andrea Breitkreuz, Claudia Tolliver, Janina Caspar, Juliane Quinkhardt, Lisa Hebich, Malte Stein, Alexander Hohberger, Isabel Vogler, Inga Liebig, Stephanie Renken, Julian Sikorski, Melanie Leierer, Verena Müller, Heidrun Mitzel-Rink, Matthias Miederer, Christoph Huber, Stephan Grabbe, Jochen Utikal, Andreas Pinter, Roland Kaufmann, Jessica C. Hassel, Carmen Loquai, Özlem Türeci
Topics & Concepts
MelanomaMedicineImmunologyAntigenImmune checkpointImmunotherapyVaccinationInterim analysisCancerImmunityCancer immunotherapyOncologyCancer researchImmune systemClinical trialInternal medicineImmunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersCAR-T cell therapy research